Skip to content

Treatment of Tinea Corporis fungal infection disease symptoms such as itching, redness, pistules etc,using Ayurvedic formulations

A single blind randomised controlled clinical study to evaluate the combined efficacy of Dvitiya edagajadi lepa and Aragvadhadi kashaya over Prathama edagajadi lepa and Aragvadhadi kashaya in Dadru kushta with special reference to Tinea Corporis - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079629
Enrollment
40
Registered
2025-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Sangeetha GM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects having the signs and symptoms like Viz Kandu, Raaga,Pidaka and Udgatam mandala. 2.Age group between 18- 65 of either sex 3.Subjects willing participate and complete with all study prescribed for prescribed trial period 4.Subjects willing to give a written consent 5.Subjects not using any topical and oral treatment for Dadru Kushta for 2 weeks prior to enrollment to study

Exclusion criteria

Exclusion criteria: 1.Any medical condition, laboratory finding or physical examination findings like vital signs outside of specific range 2.If patient is on any concomitant medication like oral contraceptive, Thyroid medication etc 3.Patients with history of systemic illness like Diabetic mellitus, Hypertension, Endocrine disorder,Cardiac pathology, Cancer, Immune system disorder like AIDS. 4.Any known allergic reaction to component of study products 5.History of drug or alcohol abuse. 6.Pregnant and lactating women 7.Patient who have taken topical or oral steroids within one month prior to enrollment 8.Patient under treatment of another Dermatological condition

Design outcomes

Primary

MeasureTime frame
1.Changes in signs and symptoms of Dadru kushta such as reduction in size and color of lesion and other symptoms like kandu, pidaka and udgatam mandala etc 2.Improvement in the scaleTimepoint: 45 days

Secondary

MeasureTime frame
1.Absence of scars from healed lesion 2.No occurrence of the sameTimepoint: 60 days

Countries

India

Contacts

Public ContactDr Sangeetha G M

Shri DGM Ayurvedic medical college, Kalsapur road, Shivanand nagar Gadag. 582103

yasmeenphaniband@gmail.com9845515865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026